PNP Therapeutics®, Inc. is a clinical-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. Learn more about PNP Therapeutics >.
News & Events
June 16, 2015 > - PNP PNP Therapeutics Inc. Receives Orphan Drug Status for Gedeptin
November 21, 2013 > PNP Therapeutics Cancer-fighting Technology Progressing Well in Phase I Clinical Trial
July 2, 2013 > PNP Therapeutics Names Claude Bennett and James Fuqua to Board of Directors